Metraipolis › archive › dc_69da74c76855
Predictive factors for HbA1c and weight loss associated with semaglutide treatment in type 2 diabetes mellitus: real-world clinical evidence — Europe PMC PMID:41036135
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41036135
- DOI
- 10.3389/fendo.2025.1621892
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-09T22:46:41.407Z
- SHA-256 of the archived text
e1f18bc7090d50d356b94f27622b528fcc8083ff5ba129cf3bbf4e6037e691d7- Stable URL of this page
https://metraipolis.com/documento/dc_69da74c76855
How to cite
Predictive factors for HbA1c and weight loss associated with semaglutide treatment in type 2 diabetes mellitus: real-world clinical evidence — Europe PMC PMID:41036135 — Europe PMC (en), https://europepmc.org/article/MED/41036135 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_69da74c76855 (Metraipolis archive dc_69da74c76855, sha256 e1f18bc7090d50d356b94f27622b528fcc8083ff5ba129cf3bbf4e6037e691d7)
BibTeX
@misc{dc69da74c76855,
title = {Predictive factors for HbA1c and weight loss associated with semaglutide treatment in type 2 diabetes mellitus: real-world clinical evidence — Europe PMC PMID:41036135},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41036135},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_69da74c76855; sha256 e1f18bc7090d50d356b94f27622b528fcc8083ff5ba129cf3bbf4e6037e691d7},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41036135. Agents can read the archived copy with the MCP tool read_document.